Your body relies on the EFNB1 gene to help cells communicate as the face, skull, limbs, and other tissues form before birth. The protein made by this gene helps guide where cells move and how neighboring tissues line up. Pathogenic variants in the EFNB1 gene can cause a condition called craniofrontonasal syndrome, which may affect head and face shape, the eyes, fingers, toes, and sometimes growth or learning. Effects vary from person to person.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, which are the active parts of cells. Others mainly direct when, where, and how much certain processes take place. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medicines. To explore this topic in more detail, you can read more in the LearnHub.
Overview
EFNB1Gene function
What if the gene works
The EFNB1 gene helps cells send signals that guide how tissues take shape during early development. It supports cell positioning and boundary formation, especially in the face, skull, skeleton, and nervous system.
Risk
What if the gene does not work
Variants in the EFNB1 gene are best known for causing craniofrontonasal syndrome, which can affect the shape of the head and face, eye spacing, and the fingers or toes. Effects can range from mild to more marked.
Treatment
What does that mean for your treatment
No EFNB1-specific treatment or drug choice is currently established for a pathogenic variant in the EFNB1 gene. The EFNB1 gene is being studied in early research on cell signaling pathways, but this has not led to guideline-based therapies.
Conditions associated with EFNB1
Gene function
What if the gene works
During early growth, nearby cells need constant contact to line up, move, and form body structures. At the cell surface, the EFNB1 gene helps neighboring cells exchange these short-range messages. This is part of how the EFNB1 gene works in early development and supports orderly tissue building.
Neighboring cells use signals from the EFNB1 gene when they touch. Its protein can relay messages in both directions, helping cells adjust position, shape, and activity together.
Its protein helps groups of cells sort into the right places and form clear boundaries. This keeps developing tissues organized so each region grows with the correct shape and layout.
Signals linked to the EFNB1 gene help cells move along controlled paths as the face, limbs, and other structures take shape. This supports smooth reshaping of tissues during normal development.
The EFNB1 gene helps cells respond to local position cues, so similar cells stay together and different groups separate when needed. That patterning supports the normal design of many developing parts of the body.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
To understand how variants influence the EFNB1 gene's function, it helps to know that some DNA changes weaken the ephrin-B1 protein, while others stop cells from making a usable protein at all. Some variants only partly reduce how well the protein connects and sends signals between nearby cells, while more disruptive variants can remove that activity almost completely. This range can influence the pattern and severity of craniofrontonasal syndrome, and in many females, a patchwork of cells with and without working ephrin-B1 can further disturb tissue organization.
How variants are linked to conditions
Pathogenic variants in the EFNB1 gene cause craniofrontonasal syndrome, a condition that can affect the shape of the head and face and may also involve the hands, feet, hair, and nails. The EFNB1 gene and craniofrontonasal syndrome link is well established, and females are often more noticeably affected than males. A confirmed disease-causing EFNB1 variant can support or confirm the diagnosis in the right clinical setting.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal feature of human biology. Most do not directly affect health and instead reflect the natural variation seen among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, a single well understood variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For EFNB1, risk is mainly shaped by whether a disease-causing variant is present, rather than by lifestyle or everyday exposures. In families with an EFNB1 variant, inheritance matters, and sex can affect how strongly features show, with females often more clearly affected than males.
Inheritance of EFNB1 variants
How EFNB1 variants are inherited follows an X linked dominant pattern. If a mother carries a disease causing variant in the EFNB1 gene, each child has a 50% chance of inheriting it. If a father carries the variant, he can pass it to all of his daughters and none of his sons, because fathers pass their X chromosome to daughters and their Y chromosome to sons. Some people with an EFNB1 related condition have a new variant that was not inherited from either parent.
What does my EFNB1 result mean for my family?
For EFNB1, family implications are usually based on an X-linked pattern. Close relatives, especially a parent, siblings, and children, may also carry the same gene change and may benefit from learning whether it runs in the family. In many living with an EFNB1-related condition, the change is new and not inherited from either parent, so a parent does not always have it.
Genetic information
Genetic testing
How you find out about variants
To find changes in the EFNB1 gene, doctors use genetic testing for EFNB1 variants, usually on a blood sample or saliva sample. A lab reads the gene’s DNA code to look for variants and may compare the result with symptoms and family history to clarify whether a variant helps explain a person’s condition.
When should I consider getting a genetic test?
Genetic testing for the EFNB1 gene may be worth considering when someone has signs of a condition that affects skull and face growth, called craniofrontonasal syndrome, often along with differences in the hands, feet, hair, or nails. It can also help when these features run in the family.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies by the condition and the type of variant involved. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, has less effect for another, or causes more side effects in someone else. These differences are common and are only one part of the picture, along with age, overall health, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect how people respond to medicines. It focuses on gene drug patterns to help explain why the same treatment may work differently in different people. With many medications, genes can influence both how the body handles a drug and how powerful its effects are. This information can support treatment choices that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the EFNB1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have side effects, new symptoms, or concerns about how well a treatment is working, talk with your doctor or pharmacist.
History
EFNB1 entered medical genetics through studies of families with craniofrontonasal syndrome, a condition whose inheritance pattern puzzled researchers for years. Initially understood only through visible traits, later recognized as tied to a specific gene, it became a striking example of how X linked conditions do not always follow the usual expectations. In the late 1990s, researchers identified variants in the EFNB1 gene as the cause in affected families, which helped resolve that long-standing puzzle. This discovery drew attention because females often showed more noticeable features than males, an unusual finding in X linked inheritance. From these first observations, research expanded steadily. EFNB1 has since held an important place in the history of developmental genetics and in how clinicians think about unusual inheritance patterns.